Ambalal Sarabhai Enterprises Share Price | Ambalal Sarabhai Enterprises Stock Screener
AMBALALSA
Pharmaceuticals
Share Price NSE
₹32.13
▼
-0.69 (-2.10%)
Share Price BSE
₹32.27
▼
-0.73 (-2.21%)
As of July 6, 2026, the Ambalal Sarabhai Enterprises share price (NSE: AMBALALSA) is ₹32.13 on NSE and ₹32.27 on BSE, down 2.10% from the previous close, with shares trading between ₹32.00 and ₹33.50, and a 52-week range of ₹30.91–₹37.30.
Analyse AMBALALSA share price charts and track historical price performance.
Use the Ambalal Sarabhai Enterprises stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Ambalal Sarabhai Enterprises Market Cap
₹251.51 Cr.
AMBALALSA P/E Ratio (TTM)
13.72
Ambalal Sarabhai Enterprises P/B Ratio
1.54
EPS (TTM)
₹2.32
Dividend Yield
-
Debt to Equity
0.35
AMBALALSA 52 Week High
₹37.30
Ambalal Sarabhai Enterprises 52 Week Low
₹30.91
Operating Margin
9.00%
Profit Margin
10.14%
AMBALALSA Revenue (TTM)
₹69.00
EBITDA
₹9.00
Net Income
₹7.00
Total Assets
₹281.00
Total Equity
₹158.00
Ambalal Sarabhai Enterprises Share Price Chart
Screen Ambalal Sarabhai Enterprises share price with an interactive chart. Analyse AMBALALSA price trends and volatility across different timeframes.
Ambalal Sarabhai Enterprises Company Profile - Fundamental Screener
Screen Ambalal Sarabhai Enterprises company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for AMBALALSA shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE432A01017
Ambalal Sarabhai Enterprises Balance Sheet Screener
Screen AMBALALSA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 281 | 270 | 250 | 246 | 231 | 210 | 186 | 215 | 200 | 164 |
| Current Assets | 125 | 119 | 119 | 111 | 120 | 121 | 104 | 116 | 114 | 73 |
| Fixed Assets | 68 | 88 | 88 | 85 | 58 | 57 | 58 | 58 | 59 | 72 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 24 | 10 | 11 | 12 | 5 | 8 | 8 | 13 | 18 | 14 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 158 | 140 | 136 | 131 | 120 | 74 | 45 | 31 | 27 | 25 |
| Share Capital | 77 | 77 | 77 | 77 | 77 | 77 | 77 | 77 | 77 | 77 |
| Reserves & Surplus | 82 | 63 | 60 | 54 | 43 | -3 | -32 | -46 | -50 | -52 |
Ambalal Sarabhai Enterprises Income Statement Screener - Profit & Revenue Analysis
Screen Ambalal Sarabhai Enterprises income statement and profit fundamentals.
Analyze AMBALALSA quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Ambalal Sarabhai Enterprises share price evaluation.
| Item | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sept |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 69 | 55 | 46 | 49 | 66 | 52 | 48 | 43 | 59 | 45 | 43 | 38 | 50 | 38 | 49 |
| Expenses | 60 | 49 | 44 | 39 | 67 | 47 | 42 | 40 | 50 | 41 | 39 | 40 | 41 | 34 | 46 |
| EBITDA | 9 | 6 | 2 | 10 | 0 | 5 | 5 | 3 | 9 | 4 | 4 | -3 | 9 | 5 | 3 |
| Operating Profit % | 9.00% | 6.00% | 1.00% | 4.00% | -3.00% | -2.00% | 6.00% | 1.00% | 9.00% | 6.00% | 3.00% | -11.00% | 8.00% | 4.00% | 2.00% |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
| Profit Before Tax | 6 | 4 | 0 | 8 | -2 | 3 | 3 | 1 | 8 | 2 | 2 | -5 | 7 | 4 | 2 |
| Tax | 0 | 1 | 1 | 0 | -2 | 1 | 1 | 1 | -1 | 1 | 1 | 0 | 1 | 0 | 1 |
| Net Profit | 7 | 4 | -1 | 8 | 0 | 2 | 3 | 0 | 9 | 1 | 1 | -5 | 6 | 3 | 1 |
| EPS | 0.85 | 0.40 | -0.07 | 1.07 | -0.04 | 0.29 | 0.34 | 0.05 | 1.18 | 0.15 | 0.14 | -0.64 | 0.72 | 0.40 | 0.13 |
Ambalal Sarabhai Enterprises Cash Flow Screener - Liquidity Fundamentals
Screen AMBALALSA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -18 | 9 | 6 | 12 | -2 | -7 | 19 | -7 | 5 | -75 |
| Investing Activities | 13 | -5 | -17 | 5 | 10 | 17 | -9 | 18 | -3 | 80 |
| Financing Activities | -2 | -3 | 9 | -19 | -6 | -14 | -6 | -2 | -6 | -3 |
| Net Cash Flow | -6 | 1 | -2 | -3 | 2 | -4 | 4 | 8 | -4 | 2 |
Ambalal Sarabhai Enterprises Shareholding Pattern Screener
See Ambalal Sarabhai Enterprises shareholding pattern with promoter, FII, and DII holdings.
Check Ambalal Sarabhai Enterprises promoter holding and ownership changes for AMBALALSA on TickJournal.
| Item | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 31.36% | 31.36% | 31.35% | 31.35% | 31.35% | 31.35% | 31.35% | 30.77% |
| FII Holding | 0.00% | 0.34% | 0.34% | 0.38% | 0.38% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.01% | 0.01% | 0.01% | 0.01% | 0.10% | 0.10% | 0.01% | 0.01% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 58.67% | 58.45% | 58.36% | 58.06% | 57.42% | 57.08% | 57.59% | 57.93% |
| Other Holding | 9.96% | 9.85% | 9.95% | 10.20% | 10.75% | 11.47% | 11.06% | 11.29% |
| Shareholder Count | 167,599 | 168,396 | 170,015 | 169,630 | 170,912 | 171,221 | 172,338 | 169,228 |
Ambalal Sarabhai Enterprises Share Dividend Screener - Share Yield Analysis
Check Ambalal Sarabhai Enterprises dividend history with payout and yield data.
View Ambalal Sarabhai Enterprises dividend details including ex-dates and amounts for AMBALALSA stock.
Ambalal Sarabhai Enterprises Stock Index Membership
See which indices include Ambalal Sarabhai Enterprises stock.
Check AMBALALSA index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Ambalal Sarabhai Enterprises Market Events Screener - Corporate Actions
Get Ambalal Sarabhai Enterprises corporate actions including splits, bonuses, and buybacks.
Check Ambalal Sarabhai Enterprises stock events that may affect AMBALALSA share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 0.33% | ||
| Extraordinary General Meeting | NA | 24.58% | ||
| Annual General Meeting | NA | 36.67% | ||
| 2026-07-30 | 2026-07-30 | Annual General Meeting | NA | -0.09% |
| 2026-05-21 | 2026-05-21 | Quarterly Result Announcement | NA | 5.78% |
| 2026-02-12 | 2026-02-12 | Quarterly Result Announcement | NA | -3.73% |
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | -3.59% |
| 2025-08-11 | 2025-08-11 | Quarterly Result Announcement | NA | -8.25% |
| 2025-07-31 | 2025-07-31 | Annual General Meeting | NA | -14.69% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | 1.28% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | 0.14% |
| 2024-11-12 | 2024-11-12 | Quarterly Result Announcement | NA | 5.94% |
| 2024-06-29 | 2024-06-29 | Annual General Meeting | NA | 2.31% |
Ambalal Sarabhai Enterprises Competitors Screener - Peer Comparison
Screen AMBALALSA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 457,025 | 39.02 | 58,220 | 6.38% | 11,565 | 69.58 |
| Divis Laboratories | 179,377 | 69.00 | 10,560 | 8.73% | 2,520 | 55.41 |
| Torrent Pharmaceuticals | 161,381 | 73.80 | 13,886 | 20.34% | 2,138 | 70.39 |
| Cipla | 117,800 | 30.47 | 29,045 | 2.24% | 3,870 | 66.80 |
| Zydus Life Science | 114,771 | 21.60 | 26,720 | 13.65% | 5,242 | 66.88 |
| Dr Reddys Laboratories | 114,692 | 27.03 | 33,593 | -0.44% | 3,998 | 67.04 |
| Lupin | 113,211 | 20.48 | 27,488 | 19.98% | 5,345 | 71.73 |
| Mankind Pharma | 104,430 | 53.00 | 14,278 | 12.03% | 1,750 | 60.79 |
| Aurobindo Pharma | 93,240 | 25.87 | 33,385 | 3.21% | 3,376 | 70.76 |
| Laurus Labs | 83,262 | 92.55 | 6,868 | 22.01% | 890 | 71.63 |
Ambalal Sarabhai Enterprises Company Announcements - News Screener
Screen AMBALALSA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-07-05 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-07-01 | Closure of Trading Window | - |
| 2026-05-27 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-24 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-21 | Shareholders Meeting Intimation | - |
| 2026-05-21 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-05-21 | Results - Financial Results As On 31.03.2026 | - |
| 2026-05-21 | Board Meeting Outcome for Outcome Of Board Meeting Held On 21.05.2026 | - |
| 2026-05-14 | Board Meeting Intimation for Approval Of Audited Financial Results As On 31.03.2026 | - |
| 2026-04-24 | Intimation Regarding Change In Branch Address Of Registrar & Share Transfer Agent (MCS Share Transfer Agent Limited) | - |
| 2026-04-21 | Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2 | - |
| 2026-04-21 | Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A | - |
| 2026-04-09 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-03-30 | Closure of Trading Window | - |
| 2026-02-16 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-02-12 | Board Meeting Outcome for Outcome Of Board Meeting | - |
| 2026-02-12 | Results - Financial Results For The Quarter And Nine Months Ended On 31.12.2025 | - |
| 2026-02-04 | Board Meeting Intimation for Approval Of Unaudited Financial Results (Standalone And Consolidated) Along With LRR Of Auditors There On For The Quarter And Nine Months Ended 31.12.2025 | - |
| 2026-01-05 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2025-12-31 | Closure of Trading Window | - |